These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16551864)

  • 1. Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
    Gilbert JA; Salavaggione OE; Ji Y; Pelleymounter LL; Eckloff BW; Wieben ED; Ames MM; Weinshilboum RM
    Clin Cancer Res; 2006 Mar; 12(6):1794-803. PubMed ID: 16551864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics.
    Adjei AA; Thomae BA; Prondzinski JL; Eckloff BW; Wieben ED; Weinshilboum RM
    Br J Pharmacol; 2003 Aug; 139(8):1373-82. PubMed ID: 12922923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
    Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
    Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies.
    Wood TC; Salavagionne OE; Mukherjee B; Wang L; Klumpp AF; Thomae BA; Eckloff BW; Schaid DJ; Wieben ED; Weinshilboum RM
    J Biol Chem; 2006 Mar; 281(11):7364-73. PubMed ID: 16407288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics.
    Martin YN; Salavaggione OE; Eckloff BW; Wieben ED; Schaid DJ; Weinshilboum RM
    Pharmacogenet Genomics; 2006 Apr; 16(4):265-77. PubMed ID: 16538173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
    Sugiyama E; Kaniwa N; Kim SR; Kikura-Hanajiri R; Hasegawa R; Maekawa K; Saito Y; Ozawa S; Sawada J; Kamatani N; Furuse J; Ishii H; Yoshida T; Ueno H; Okusaka T; Saijo N
    J Clin Oncol; 2007 Jan; 25(1):32-42. PubMed ID: 17194903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics.
    Kocabas NA; Aksoy P; Pelleymounter LL; Moon I; Ryu JS; Gilbert JA; Salavaggione OE; Eckloff BW; Wieben ED; Yee V; Weinshilboum RM; Ames MM
    Drug Metab Dispos; 2008 Sep; 36(9):1951-9. PubMed ID: 18556440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Cytidine Deaminase to Thymidylate Biosynthesis in Trypanosoma brucei: Intracellular Localization and Properties of the Enzyme.
    Moro-Bulnes A; Castillo-Acosta VM; Valente M; Carrero-Lérida J; Pérez-Moreno G; Ruiz-Pérez LM; González-Pacanowska D
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
    Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hydroxysteroid sulfotransferase SULT2B1 pharmacogenomics: gene sequence variation and functional genomics.
    Ji Y; Moon I; Zlatkovic J; Salavaggione OE; Thomae BA; Eckloff BW; Wieben ED; Schaid DJ; Weinshilboum RM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):529-40. PubMed ID: 17496163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.
    Sugiyama E; Lee SJ; Lee SS; Kim WY; Kim SR; Tohkin M; Hasegawa R; Okuda H; Kawamoto M; Kamatani N; Sawada J; Kaniwa N; Saito Y; Shin JG
    Drug Metab Pharmacokinet; 2009; 24(6):553-6. PubMed ID: 20045991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
    Cohen R; Preta LH; Joste V; Curis E; Huillard O; Jouinot A; Narjoz C; Thomas-Schoemann A; Bellesoeur A; Tiako Meyo M; Quilichini J; Desaulle D; Nicolis I; Cessot A; Vidal M; Goldwasser F; Alexandre J; Blanchet B
    Br J Clin Pharmacol; 2019 Jun; 85(6):1227-1238. PubMed ID: 30701582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.
    Metharom E; Galettis P; Manners S; Jelinek M; Liauw W; de Souza PL; Hoskins JM; Links M
    Asia Pac J Clin Oncol; 2011 Mar; 7(1):65-74. PubMed ID: 21332653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.
    Raynal C; Ciccolini J; Mercier C; Boyer JC; Polge A; Lallemant B; Mouzat K; Lumbroso S; Brouillet JP; Evrard A
    Ther Drug Monit; 2010 Feb; 32(1):53-60. PubMed ID: 20010457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics.
    Mukherjee B; Salavaggione OE; Pelleymounter LL; Moon I; Eckloff BW; Schaid DJ; Wieben ED; Weinshilboum RM
    Drug Metab Dispos; 2006 Jul; 34(7):1237-46. PubMed ID: 16638819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.
    Pereira NL; Aksoy P; Moon I; Peng Y; Redfield MM; Burnett JC; Wieben ED; Yee VC; Weinshilboum RM
    J Mol Cell Cardiol; 2010 Nov; 49(5):864-74. PubMed ID: 20692264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.
    Aksoy P; Zhu MJ; Kalari KR; Moon I; Pelleymounter LL; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM; Wang L
    Pharmacogenet Genomics; 2009 Aug; 19(8):567-76. PubMed ID: 19623099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.
    Fitzgerald SM; Goyal RK; Osborne WR; Roy JD; Wilson JW; Ferrell RE
    Hum Genet; 2006 Apr; 119(3):276-83. PubMed ID: 16446974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine.
    Zhou M; Ding YJ; Feng Y; Zhang QR; Xiang Y; Wan HY
    Genet Mol Res; 2014 Apr; 13(2):3310-8. PubMed ID: 24841663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
    Sugiyama E; Kaniwa N; Kim SR; Hasegawa R; Saito Y; Ueno H; Okusaka T; Ikeda M; Morizane C; Kondo S; Yamamoto N; Tamura T; Furuse J; Ishii H; Yoshida T; Saijo N; Sawada J
    Clin Pharmacokinet; 2010 Aug; 49(8):549-58. PubMed ID: 20608756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.